Trials / Conditions / Transformed Mycosis Fungoides
Transformed Mycosis Fungoides
4 registered clinical trials studyying Transformed Mycosis Fungoides — 1 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Active Not Recruiting | Dose-Escalation and Dose-Expansion Study to Evaluate the Safety and Tolerability of Anti-CD7 Allogeneic CAR T- NCT05377827 | Washington University School of Medicine | Phase 1 |
| Recruiting | Extracorporeal Photopheresis and Mogamulizumab for the Treatment of Erythrodermic Cutaneous T Cell Lymphoma NCT04930653 | City of Hope Medical Center | Phase 2 |
| Completed | Phase II Study to Assess AFM13 in Patients With R/R CD30-positive T-cell Lymphoma or Transformed Mycosis Fungo NCT04101331 | Affimed GmbH | Phase 2 |
| Completed | Mechlorethamine Induced Contact Dermatitis Avoidance Study NCT03380026 | Rochester Skin Lymphoma Medical Group, PLLC | Phase 2 |